Lv12
40 积分 2022-01-19 加入
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor
58分钟前
已完结
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
20小时前
已完结
HDL in innate and adaptive immunity
14天前
已完结
LDL-C augments whereas HDL-C prevents inflammatory innate immune memory
24天前
已完结
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
29天前
已完结
A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation
1个月前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
1个月前
已关闭
The next generation of immunotherapies for lung cancers
1个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
4个月前
已完结
The nuclear export protein XPO1 — from biology to targeted therapy
4个月前
已完结
皖公网安备34019202002308
